KRISTIN ECKEL-MAHAN to Liver Neoplasms
This is a "connection" page, showing publications KRISTIN ECKEL-MAHAN has written about Liver Neoplasms.
Connection Strength
1.446
-
Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Rep. 2025 Nov 25; 44(11):116313.
Score: 0.440
-
Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. FASEB J. 2022 09; 36(9):e22482.
Score: 0.354
-
HNF4a-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Res. 2019 11 15; 79(22):5860-5873.
Score: 0.289
-
Incompatibility of the circadian protein BMAL1 and HNF4a in hepatocellular carcinoma. Nat Commun. 2018 10 19; 9(1):4349.
Score: 0.271
-
Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight. 2023 Jan 24; 8(2).
Score: 0.091